Cell freezing medium capable of being directly infused intravenously
The invention discloses a cell cryopreservation solution capable of being directly infused intravenously, which relates to the technical field of cell cryopreservation and comprises 9-20w/v% of dimethyl sulfoxide, 1-1000U/ml of heparin sodium, 0.3-5.5 w/v% of ticlopidine hydrochloride, 0.3-5.5 w/v%...
Gespeichert in:
Hauptverfasser: | , , , |
---|---|
Format: | Patent |
Sprache: | chi ; eng |
Schlagworte: | |
Online-Zugang: | Volltext bestellen |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | The invention discloses a cell cryopreservation solution capable of being directly infused intravenously, which relates to the technical field of cell cryopreservation and comprises 9-20w/v% of dimethyl sulfoxide, 1-1000U/ml of heparin sodium, 0.3-5.5 w/v% of ticlopidine hydrochloride, 0.3-5.5 w/v% of nitrate esters and a medical injection containing 2-25w/v% of human serum albumin, the nitrates comprise one of nitroglycerin, isosorbide dinitrate, isosorbide mononitrate and pentaerythrityl tetranitrate, and the medical injection comprises one or more than two of normal saline, sterile water for injection, a nitrate injection or a ticlopidine hydrochloride injection. The nitrate ester has the effects of expanding blood vessels, inhibiting platelet aggregation and adhesion and resisting thrombosis, adhesion development of immune cells or primary cells in the cell cryopreservation liquid is effectively reduced, the activity of the immune cells is kept, and the cell cryopreservation liquid does not need fetal cal |
---|